Liver Cancer Publications

2022

Adjusting Barcelona Clinic Liver Cancer Staging System to the Evolving Landscape of Hepatocellular Carcinoma: A Look to the Future.Strazzabosco M, Cabibbo G, Colombo M. Gastroenterology. 2022 Jun; 2022 Feb 2. PMID: 35122767.
Letter to the editor: Both universal screening and vaccination are essential components of a multipronged approach to hepatitis B elimination.Pan CQ, Jacobson IM, Martin P, Kwo P, Lim J, Han SB, Hu KQ, Ahn J, Tong MJ. Hepatology. 2022 Jun; 2022 Mar 4. PMID: 35092080.
PD-1 targeted immunotherapy for advanced hepatocellular carcinoma: current utilization and outcomes in the USA.Uhlig J, Stein S, Kim HS. Future Oncol. 2022 May; 2022 Feb 17. PMID: 35172633.
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.Asrani SK, Ghabril MS, Kuo A, Merriman RB, Morgan T, Parikh ND, Ovchinsky N, Kanwal F, Volk ML, Ho C, Serper M, Mehta S, Agopian V, Cabrera R, Chernyak V, El-Serag HB, Heimbach J, Ioannou GN, Kaplan D, Marrero J, Mehta N, Singal A, Salem R, Taddei T, Walling AM, Tapper EB. Hepatology. 2022 May; 2021 Dec 20. PMID: 34778999.
MRI Biomarkers for Prediction of Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma: Qualitative and Quantitative Assessment of LI-RADS and Radiomic Features.Petukhova-Greenstein A, Zeevi T, Yang J, Chai N, DiDomenico P, Deng Y, Ciarleglio M, Haider SP, Onyiuke I, Malpani R, Lin M, Kucukkaya A, Gottwald LA, Gebauer B, Revzin M, Onofrey J, Staib L, Gunabushanam G, Taddei T, Chapiro J. J Vasc Interv Radiol. 2022 Apr 20; 2022 Apr 20. PMID: 35460887.
Hepatocellular adenoma: Where are we now?Wang X, Zhang X. World J Gastroenterol. 2022 Apr 14. PMID: 35582672.
Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.Doemel LA, Santana JG, Savic LJ, Gaupp FML, Borde T, Petukhova-Greenstein A, Kucukkaya AS, Schobert IT, Hamm CA, Gebauer B, Walsh JJ, Rexha I, Hyder F, Lin M, Madoff DC, Schlachter T, Chapiro J, Coman D. Eur Radiol. 2022 Apr; 2021 Oct 31. PMID: 34718844.
Cytoskeletal dynamics regulates stromal invasion behavior of distinct liver cancer subtypes.Nguyen RY, Xiao H, Gong X, Arroyo A, Cabral AT, Fischer TT, Flores KM, Zhang X, Robert ME, Ehrlich BE, Mak M. Commun Biol. 2022 Mar 3; 2022 Mar 3. PMID: 35241781.
Treatment and prevention of viral hepatitis in pregnancy.Dionne-Odom J, Cozzi GD, Franco RA, Njei B, Tita ATN. Am J Obstet Gynecol. 2022 Mar; 2021 Sep 10. PMID: 34516961.
Quantitative Automated Segmentation of Lipiodol Deposits on Cone-Beam CT Imaging Acquired during Transarterial Chemoembolization for Liver Tumors: A Deep Learning Approach.Malpani R, Petty CW, Yang J, Bhatt N, Zeevi T, Chockalingam V, Raju R, Petukhova-Greenstein A, Santana JG, Schlachter TR, Madoff DC, Chapiro J, Duncan J, Lin M. J Vasc Interv Radiol. 2022 Mar; 2021 Dec 16. PMID: 34923098.
Hepatocellular Carcinoma: Does the Background Liver With or Without Cirrhosis Matter?Jain A, Mazer B, Deng Y, Ciarleglio M, Jain D, Taddei T, Zhang X. Am J Clin Pathol. 2022 Feb 3. PMID: 34542582.
Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.Nam D, Chapiro J, Paradis V, Seraphin TP, Kather JN. JHEP Rep. 2022 Apr; 2022 Feb 2. PMID: 35243281.
Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.John BV, Dahman B, Deng Y, Khakoo NS, Taddei TH, Kaplan DE, Levy C. Liver Int. 2022 Feb; 2021 Oct 12. PMID: 34614294.
Pathogenic BRCA2 germline variants in combined hepatocellular-cholangiocarcinoma.Li H, Zhang X, Finberg KE, Walther Z, Jain D, Gibson J. Pathol Int. 2022 Feb; 2021 Nov 22. PMID: 34808016.
HNF-1β is a More Sensitive and Specific Marker Than C-Reactive Protein for Identifying Biliary Differentiation in Primary Hepatic Carcinomas.Patil PA, Taddei T, Jain D, Zhang X. Arch Pathol Lab Med. 2022 Jan 2. PMID: 34086854.
Oral Cyanobacteria and Hepatocellular Carcinoma.Hernandez BY, Zhu X, Risch HA, Lu L, Ma X, Irwin ML, Lim JK, Taddei TH, Pawlish KS, Stroup AM, Brown R, Wang Z, Wong LL, Yu H. Cancer Epidemiol Biomarkers Prev. 2022 Jan; 2021 Oct 25. PMID: 34697061.

2021

Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.Ghani MA, Fereydooni A, Chen E, Letzen B, Laage-Gaupp F, Nezami N, Deng Y, Gan G, Thakur V, Lin M, Papademetris X, Schernthaner RE, Huber S, Chapiro J, Hong K, Georgiades C. Eur Radiol. 2021 Dec; 2021 Jun 1. PMID: 34061209.
Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging.Gross M, Spektor M, Jaffe A, Kucukkaya AS, Iseke S, Haider SP, Strazzabosco M, Chapiro J, Onofrey JA. PLoS One. 2021; 2021 Dec 1. PMID: 34852007.
Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure.Frangakis C, Sohn JH, Bas A, Chapiro J, Schernthaner RE, Lin M, Hamilton JP, Pawlik TM, Hong K, Duran R. Front Oncol. 2021; 2021 Nov 5. PMID: 34804911.
Lipiodol Deposition and Washout in Primary and Metastatic Liver Tumors After Chemoembolization.Nezami N, VAN Breugel JMM, Konstantinidis M, Chapiro J, Savic LJ, Miszczuk MA, Rexha I, Lin M, Hong K, Georgiades C. In Vivo. 2021 Nov-Dec. PMID: 34697157.
Machine Learning-Based Surveillance Strategy after Complete Ablation of Initially Recurrent Hepatocellular Carcinoma: Worth the Risk?Nam D, Chapiro J. J Vasc Interv Radiol. 2021 Nov. PMID: 34717834.
Adiposity, Adulthood Weight Change, and Risk of Incident Hepatocellular Carcinoma.Simon TG, Kim MN, Luo X, Liu X, Yang W, Ma Y, Chong DQ, Fuchs CS, Stampfer M, Giovannucci EL, Chan AT, Zhang X. Cancer Prev Res (Phila). 2021 Oct; 2021 Jul 15. PMID: 34266856.
Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial.Letzen BS, Malpani R, Miszczuk M, de Ruiter QMB, Petty CW, Rexha I, Nezami N, Laage-Gaupp F, Lin M, Schlachter TR, Chapiro J. Clin Imaging. 2021 Oct; 2021 May 18. PMID: 34022765.
Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.John BV, Khakoo NS, Schwartz KB, Aitchenson G, Levy C, Dahman B, Deng Y, Goldberg DS, Martin P, Kaplan DE, Taddei TH. Am J Gastroenterol. 2021 Sep 1. PMID: 33989225.
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.Kim HN, Newcomb CW, Carbonari DM, Roy JA, Torgersen J, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Sun J, Hull M, Gill MJ, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Lo Re V 3rd. Hepatology. 2021 Sep; 2021 Jun 22. PMID: 33780007.
Calcifying nested stromal-epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations.Papke DJ Jr, Dong F, Zhang X, Kozielski R, Basturk O, Fletcher CDM, Zhao L. Mod Pathol. 2021 Sep; 2021 May 16. PMID: 33994539.
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.Sellers CM, Uhlig J, Ludwig JM, Pollak JS, Taddei TH, Stein SM, Lim JK, Kim HS. Cancer Med. 2021 Aug; 2021 Jul 28. PMID: 34318618.
Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinoma.Chai NX, Chapiro J, Petukhova A, Gross M, Kucukkaya A, Raju R, Zeevi T, Elbanan M, Lin M, Perez-Lozada JC, Schlachter T, Strazzabosco M, Pollak JS, Madoff DC. Clin Imaging. 2021 Aug; 2021 Feb 11. PMID: 33592550.
Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis.John BV, Aitcheson G, Schwartz KB, Khakoo NS, Dahman B, Deng Y, Goldberg D, Martin P, Taddei TH, Levy C, Kaplan DE. Hepatology. 2021 Aug; 2021 May 26. PMID: 33636012.
Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.Oestmann PM, Wang CJ, Savic LJ, Hamm CA, Stark S, Schobert I, Gebauer B, Schlachter T, Lin M, Weinreb JC, Batra R, Mulligan D, Zhang X, Duncan JS, Chapiro J. Eur Radiol. 2021 Jul; 2021 Jan 6. PMID: 33409782.
Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis?Kumar D, Hafez O, Jain D, Zhang X. Hum Pathol. 2021 Jul; 2021 Apr 24. PMID: 33905775.
Cost-Effectiveness of Imaging Tumor Response Criteria in Hepatocellular Cancer After Transarterial Chemoembolization.Wu X, Chapiro J, Malhotra A. J Am Coll Radiol. 2021 Jul; 2021 Jan 20. PMID: 33484726.
Anatomy-guided multimodal registration by learning segmentation without ground truth: Application to intraprocedural CBCT/MR liver segmentation and registration.Zhou B, Augenfeld Z, Chapiro J, Zhou SK, Liu C, Duncan JS. Med Image Anal. 2021 Jul; 2021 Mar 21. PMID: 33823397.
α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.Lu SX, Huang YH, Liu LL, Zhang CZ, Yang X, Yang YZ, Shao CK, Li JM, Xie D, Zhang X, Jain D, Yun JP. Br J Cancer. 2021 Jun; 2021 Apr 6. PMID: 33824478.
Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.Doemel LA, Chapiro J, Laage Gaupp F, Savic LJ, Kucukkaya AS, Petukhova A, Tefera J, Zeevi T, Lin M, Schlachter T, Jaffe A, Strazzabosco M, Patel T, Stein SM. Eur Radiol. 2021 May; 2020 Oct 30. PMID: 33123796.
Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.Savic LJ, Chapiro J, Funai E, Bousabarah K, Schobert IT, Isufi E, Geschwind JH, Stark S, He P, Rudek MA, Perez Lozada JC, Ayyagari R, Pollak J, Schlachter T. Eur Radiol. 2021 May; 2020 Oct 15. PMID: 33063185.
Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Noncompletion in the Veterans Health Administration Cohort During the Coronavirus Disease 2019 Pandemic.Mahmud N, Kaplan DE, Goldberg DS, Taddei TH, Serper M. Gastroenterology. 2021 May; 2021 Jan 9. PMID: 33434604.
Liver Pathologic Changes After Direct-Acting Antiviral Agent Therapy and Sustained Virologic Response in the Setting of Chronic Hepatitis C Virus Infection.Celli R, Saffo S, Kamili S, Wiese N, Hayden T, Taddei T, Jain D. Arch Pathol Lab Med. 2021 Apr 1. PMID: 32810870.
Elastin-specific MRI of extracellular matrix-remodelling following hepatic radiofrequency-ablation in a VX2 liver tumor model.Collettini F, Reimann C, Brangsch J, Chapiro J, Savic LJ, Onthank DC, Robinson SP, Karst U, Buchholz R, Keller S, Hamm B, Goldberg SN, Makowski MR. Sci Rep. 2021 Mar 25; 2021 Mar 25. PMID: 33767303.
A Novel Treatment for Metastatic Serous Cystadenocarcinoma Using a Microwave Ablation: Case Report and Review of the Literature.Murtha TD, Cornman-Homonoff J, Ayyagari R, Zhang X, Salem RR. Pancreas. 2021 Mar 1. PMID: 33835976.
Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.Sun J, Althoff KN, Jing Y, Horberg MA, Buchacz K, Gill MJ, Justice AC, Rabkin CS, Goedert JJ, Sigel K, Cachay E, Park L, Lim JK, Kim HN, Lo Re V 3rd, Moore R, Sterling T, Peters MG, Achenbach CJ, Silverberg M, Thorne JE, Mayor AM, Crane HM, Kitahata MM, Klein M, Kirk GD. JAMA Netw Open. 2021 Feb 1; 2021 Feb 1. PMID: 33595662.
Automated detection and delineation of hepatocellular carcinoma on multiphasic contrast-enhanced MRI using deep learning.Bousabarah K, Letzen B, Tefera J, Savic L, Schobert I, Schlachter T, Staib LH, Kocher M, Chapiro J, Lin M. Abdom Radiol (NY). 2021 Jan; 2020 Jun 4. PMID: 32500237.
Fibronodular hepatocellular carcinoma-a new variant of liver cancer: clinical, pathological and radiological correlation.Tefera J, Revzin M, Chapiro J, Savic LJ, Mulligan D, Batra R, Taddei T, Jain D, Zhang X. J Clin Pathol. 2021 Jan; 2020 May 19. PMID: 32430483.
Comparison of Drug-Eluting Embolics versus Conventional Transarterial Chemoembolization for the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.Wu X, Chapiro J, Malhotra A, Kothary N. J Vasc Interv Radiol. 2021 Jan; 2020 Nov 5. PMID: 33160827.

2020

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Gade TP, Goff L, Gupta S, Guy J, Harris WP, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Knox JJ, Kortmansky J, Leaf A, Remak WM, Shroff RT, Sohal DPS, Taddei TH, Venepalli NK, Wilson A, Zhu AX, Rose MG. J Clin Oncol. 2020 Dec 20; 2020 Nov 16. PMID: 33197225.
Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Bräu N, Brown ST, Taddei TH, Justice AC, Lo Re V 3rd. J Acquir Immune Defic Syndr. 2020 Dec 15. PMID: 33185999.
Assessing the Impact of Referral on Multidisciplinary Tumor Board Outcomes in Patients With Hepatocellular Carcinoma.Zhang Y, Weinreb JC, Czeyda-Pommersheim F, Taddei TH. J Am Coll Radiol. 2020 Dec; 2020 Jun 10. PMID: 32533924.
Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.Chai NX, Chapiro J. Semin Intervent Radiol. 2020 Dec; 2020 Dec 11. PMID: 33328701.
Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine.Vyas M, Zhang X. Clin Liver Dis. 2020 Nov; 2020 Sep 3. PMID: 33012447.
Health related quality of life in chronic liver diseases.Cortesi PA, Conti S, Scalone L, Jaffe A, Ciaccio A, Okolicsanyi S, Rota M, Fabris L, Colledan M, Fagiuoli S, Belli LS, Cesana G, Strazzabosco M, Mantovani LG. Liver Int. 2020 Nov. PMID: 32851764.
Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer.Stark S, Wang C, Savic LJ, Letzen B, Schobert I, Miszczuk M, Murali N, Oestmann P, Gebauer B, Lin M, Duncan J, Schlachter T, Chapiro J. Sci Rep. 2020 Oct 22; 2020 Oct 22. PMID: 33093524.
Getting to implementation: a protocol for a Hybrid III stepped wedge cluster randomized evaluation of using data-driven implementation strategies to improve cirrhosis care for Veterans.Rogal SS, Yakovchenko V, Morgan T, Bajaj JS, Gonzalez R, Park A, Beste L, Miech EJ, Lamorte C, Neely B, Gibson S, Malone PS, Chartier M, Taddei T, Garcia-Tsao G, Powell BJ, Dominitz JA, Ross D, Chinman MJ. Implement Sci. 2020 Oct 21; 2020 Oct 21. PMID: 33087156.
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.Schobert IT, Savic LJ, Chapiro J, Bousabarah K, Chen E, Laage-Gaupp F, Tefera J, Nezami N, Lin M, Pollak J, Schlachter T. Eur Radiol. 2020 Oct; 2020 May 19. PMID: 32424595.
Idarubicin-Loaded ONCOZENE Drug-Eluting Bead Chemoembolization in a Rabbit Liver Tumor Model: Investigating Safety, Therapeutic Efficacy, and Effects on Tumor Microenvironment.Borde T, Laage Gaupp F, Geschwind JF, Savic LJ, Miszczuk M, Rexha I, Adam L, Walsh JJ, Huber S, Duncan JS, Peters DC, Sinusas A, Schlachter T, Gebauer B, Hyder F, Coman D, van Breugel JMM, Chapiro J. J Vasc Interv Radiol. 2020 Oct; 2020 Jul 17. PMID: 32684417.
Prevalence of Chronic Hepatitis B Virus Infection in the United States.Lim JK, Nguyen MH, Kim WR, Gish R, Perumalswami P, Jacobson IM. Am J Gastroenterol. 2020 Sep. PMID: 32483003.
Quantitative MRI for Assessment of Treatment Outcomes in a Rabbit VX2 Hepatic Tumor Model.Keller S, Chapiro J, Brangsch J, Reimann C, Collettini F, Sack I, Savic LJ, Hamm B, Goldberg SN, Makowski M. J Magn Reson Imaging. 2020 Sep; 2019 Nov 12. PMID: 31713973.
Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?Savic LJ, Doemel LA, Schobert IT, Montgomery RR, Joshi N, Walsh JJ, Santana J, Pekurovsky V, Zhang X, Lin M, Adam L, Boustani A, Duncan J, Leng L, Bucala RJ, Goldberg SN, Hyder F, Coman D, Chapiro J. Radiology. 2020 Sep; 2020 Jul 7. PMID: 32633675.
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Gibert CL, Bräu N, Brown ST, Roy JA, Taddei TH, Justice AC, Lo Re V. J Natl Cancer Inst. 2020 Jul 1. PMID: 31687755.
Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts.Simon TG, Kim MN, Luo X, Yang W, Ma Y, Chong DQ, Fuchs CS, Meyerhardt JA, Corey KE, Chung RT, Stampfer M, Zhang X, Giovannucci EL, Chan AT. J Hepatol. 2020 Jun; 2020 Jan 15. PMID: 31954204.
Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma.Kamp WM, Sellers CM, Stein S, Lim JK, Kim HS. J Vasc Interv Radiol. 2020 Jun; 2020 May 4. PMID: 32376182.
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.Lee MS, Ryoo BY, Hsu CH, Numata K, Stein S, Verret W, Hack SP, Spahn J, Liu B, Abdullah H, Wang Y, He AR, Lee KH. Lancet Oncol. 2020 Jun. PMID: 32502443.
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.Loomba R, Lim JK, Patton H, El-Serag HB. Gastroenterology. 2020 May; 2020 Jan 30. PMID: 32006545.
Extracellular pH mapping of liver cancer on a clinical 3T MRI scanner.Coman D, Peters DC, Walsh JJ, Savic LJ, Huber S, Sinusas AJ, Lin M, Chapiro J, Constable RT, Rothman DL, Duncan JS, Hyder F. Magn Reson Med. 2020 May; 2019 Nov 5. PMID: 31691371.
Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.Shen Y, Risch H, Lu L, Ma X, Irwin ML, Lim JK, Taddei T, Pawlish K, Stroup A, Brown R, Wang Z, Jia W, Wong L, Mayne ST, Yu H. Cancer Causes Control. 2020 Apr; 2020 Feb 14. PMID: 32060838.
Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?Luedemann WM, Geisel D, Gebauer B, Schnapauff D, Chapiro J, Wieners G, Steffen I, Kahn J. Eur Radiol. 2020 Mar; 2019 Dec 6. PMID: 31811428.
Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment.Savic LJ, Schobert IT, Peters D, Walsh JJ, Laage-Gaupp FM, Hamm CA, Tritz N, Doemel LA, Lin M, Sinusas A, Schlachter T, Duncan JS, Hyder F, Coman D, Chapiro J. Clin Cancer Res. 2020 Jan 15; 2019 Oct 3. PMID: 31582517.
Differences in Pathology, Staging, and Treatment between HIV⁺ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma.Torgersen J, Taddei TH, Park LS, Carbonari DM, Kallan MJ, Mitchell Richards K, Zhang X, Jhala D, Bräu N, Homer R, D'Addeo K, Mehta R, Skanderson M, Kidwai-Khan F, Justice AC, Lo Re V 3rd. Cancer Epidemiol Biomarkers Prev. 2020 Jan; 2019 Oct 1. PMID: 31575557.
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.Strazzabosco M, Cortesi PA, Conti S, Okolicsanyi S, Rota M, Ciaccio A, Cozzolino P, Fornari C, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Zavaglia C, Perricone G, Munari LM, Mantovani LG, Belli LS. Liver Int. 2020 Jan; 2019 Nov 12. PMID: 31654608.
Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma.Kanneganti M, Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Transplantation. 2020 Jan. PMID: 31283688.

2019

Hepatocellular carcinoma: Impact of academic setting and hospital volume on patient survival.Uhlig J, Sellers CM, Khan SA, Cha C, Kim HS. Surg Oncol. 2019 Dec; 2019 Oct 12. PMID: 31654956.
Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma.Kamp WM, Sellers CM, Stein S, Lim JK, Kim HS. Sci Rep. 2019 Nov 19; 2019 Nov 19. PMID: 31745132.
AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.Bowlus CL, Lim JK, Lindor KD. Clin Gastroenterol Hepatol. 2019 Nov; 2019 Jul 12. PMID: 31306801.
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.Ioannou GN, Beste LA, Green PK, Singal AG, Tapper EB, Waljee AK, Sterling RK, Feld JJ, Kaplan DE, Taddei TH, Berry K. Gastroenterology. 2019 Nov; 2019 Jul 26. PMID: 31356807.
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, Huang C, Li J, Dong X, Zhou Y, Liu Q, Ma L, Wang X, Zhou J, Liu Y, Boja E, Robles AI, Ma W, Wang P, Li Y, Ding L, Wen B, Zhang B, Rodriguez H, Gao D, Zhou H, Fan J. Cell. 2019 Oct 3. PMID: 31585088.
The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance.Sellers CM, Uhlig J, Ludwig JM, Taddei T, Stein SM, Lim JK, Kim HS. Cancer Med. 2019 Oct; 2019 Aug 22. PMID: 31436905.
Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.Dendy MS, Ludwig JM, Stein SM, Kim HS. Liver Cancer. 2019 Oct; 2019 Jan 16. PMID: 31768343.
Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.Balitzer D, Joseph NM, Ferrell L, Shafizadeh N, Jain D, Zhang X, Yeh M, di Tommaso L, Kakar S. Mod Pathol. 2019 Oct; 2019 Jun 11. PMID: 31186529.
Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors.Schobert I, Chapiro J, Pucar D, Saperstein L, Savic LJ. PET Clin. 2019 Oct; 2019 Aug 7. PMID: 31472741.
Expression of the type 3 InsP₃ receptor is a final common event in the development of hepatocellular carcinoma.Guerra MT, Florentino RM, Franca A, Lima Filho AC, Dos Santos ML, Fonseca RC, Lemos FO, Fonseca MC, Kruglov E, Mennone A, Njei B, Gibson J, Guan F, Cheng YC, Ananthanarayanan M, Gu J, Jiang J, Zhao H, Lima CX, Vidigal PT, Oliveira AG, Nathanson MH, Leite MF. Gut. 2019 Sep; 2019 Jul 17. PMID: 31315892.
Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.Lo Re V 3rd, Newcomb CW, Carbonari DM, Roy JA, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Hull M, Gill J, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Kim HN. J Acquir Immune Defic Syndr. 2019 Sep 1. PMID: 31107304.
Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma.Kokabi N, Nezami N, Xing M, Ludwig JM, Strazzabosco M, Kim HS. J Comp Eff Res. 2019 Sep; 2019 Sep 12. PMID: 31512955.
Quantitative Imaging Biomarkers for ⁹⁰Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization.Schobert I, Chapiro J, Nezami N, Hamm CA, Gebauer B, Lin M, Pollak J, Saperstein L, Schlachter T, Savic LJ. J Nucl Med. 2019 Aug; 2019 Jan 17. PMID: 30655331.
Macrotrabecular Hepatocellular Carcinoma: An Aggressive Subtype of Hepatocellular Carcinoma.Jeon Y, Benedict M, Taddei T, Jain D, Zhang X. Am J Surg Pathol. 2019 Jul. PMID: 31135484.
Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.Mahmud N, John B, Taddei TH, Goldberg DS. Clin Transplant. 2019 Jul; 2019 Jun 25. PMID: 31177570.
Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features.Wang CJ, Hamm CA, Savic LJ, Ferrante M, Schobert I, Schlachter T, Lin M, Weinreb JC, Duncan JS, Chapiro J, Letzen B. Eur Radiol. 2019 Jul; 2019 May 15. PMID: 31093705.
Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI.Hamm CA, Wang CJ, Savic LJ, Ferrante M, Schobert I, Schlachter T, Lin M, Duncan JS, Weinreb JC, Chapiro J, Letzen B. Eur Radiol. 2019 Jul; 2019 Apr 23. PMID: 31016442.
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.Singal AG, Lim JK, Kanwal F. Gastroenterology. 2019 Jun; 2019 Mar 13. PMID: 30878469.
Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model.van Breugel JMM, Geschwind JF, Mirpour S, Savic LJ, Zhang X, Duran R, Lin M, Miszczuk M, Liapi E, Chapiro J. Theranostics. 2019; 2019 May 27. PMID: 31281506.
Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.Uhlig J, Sellers CM, Stein SM, Kim HS. Eur Radiol. 2019 May; 2018 Dec 17. PMID: 30560364.
Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B.Fox RK, Taddei TH, Kaplan DE. JAMA Intern Med. 2019 May 1. PMID: 30882884.
Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies.Saffo S, Taddei TH. Dig Dis Sci. 2019 Apr. PMID: 30887150.
Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B.Nguyen MH, Lim JK, Burak Ozbay A, Fraysse J, Liou I, Meyer N, Dusheiko G, Gordon SC. Hepatology. 2019 Mar; 2019 Feb 11. PMID: 30175482.
Calcifying Nested Stromal-Epithelial Tumor of the Liver: An Update and Literature Review.Benedict M, Zhang X. Arch Pathol Lab Med. 2019 Feb; 2018 Oct 24. PMID: 30354275.
A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.Lee HM, Ahn J, Kim WR, Lim JK, Nguyen M, Pan CQ, Kim D, Mannalithara A, Te H, Trinh H, Chu D, Tran T, Woog J, Lok AS. Dig Dis Sci. 2019 Feb; 2018 Sep 20. PMID: 30238203.
NASH and HCC Are Driven by Different Signaling Pathways with a Common Regulator.Mehal W. Cell Metab. 2019 Jan 8. PMID: 30625307.
Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.Nguyen MH, Burak Ozbay A, Liou I, Meyer N, Gordon SC, Dusheiko G, Lim JK. J Hepatol. 2019 Jan; 2018 Oct 1. PMID: 30287341.
The Role of Artificial Intelligence in Interventional Oncology: A Primer.Letzen B, Wang CJ, Chapiro J. J Vasc Interv Radiol. 2019 Jan; 2018 Dec 7. PMID: 30528289.

2018

Irinotecan-Eluting 75-150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study.Fereydooni A, Letzen B, Ghani MA, Miszczuk MA, Huber S, Chapiro J, Schlachter T, Geschwind JF, Georgiades C. J Vasc Interv Radiol. 2018 Dec; 2018 Oct 15. PMID: 30337148.
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.Simon TG, Ma Y, Ludvigsson JF, Chong DQ, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Chung RT, Zhang X, Chan AT. JAMA Oncol. 2018 Dec 1. PMID: 30286235.
Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched Analysis.Njei B, McCarty TR, Sharma P, Lange A, Najafian N, Ngu JN, Ngomba VE, Echouffo-Tcheugui JB. Obes Surg. 2018 Dec. PMID: 30069863.
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma.Abajian A, Murali N, Savic LJ, Laage-Gaupp FM, Nezami N, Duncan JS, Schlachter T, Lin M, Geschwind JF, Chapiro J. J Vis Exp. 2018 Oct 10; 2018 Oct 10. PMID: 30371657.
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.Belli LS, Perricone G, Adam R, Cortesi PA, Strazzabosco M, Facchetti R, Karam V, Salizzoni M, Andujar RL, Fondevila C, De Simone P, Morelli C, Fabregat-Prous J, Samuel D, Agarwaal K, Moreno Gonzales E, Charco R, Zieniewicz K, De Carlis L, Duvoux C. J Hepatol. 2018 Oct; 2018 Jun 27. PMID: 29940268.
Successful treatment of primary donor-derived human herpesvirus-8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipient.Fu W, Merola J, Malinis M, Lacy J, Barbieri A, Liapakis AH, Mulligan DC, Yoo PS. Transpl Infect Dis. 2018 Oct; 2018 Aug 23. PMID: 30014622.
Hepatocellular Carcinoma Outcome Is Predicted by Expression of Neuronal Calcium Sensor 1.Schuette D, Moore LM, Robert ME, Taddei TH, Ehrlich BE. Cancer Epidemiol Biomarkers Prev. 2018 Sep; 2018 May 22. PMID: 29789326.
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions.Ippolito D, Querques G, Okolicsanyi S, Talei Franzesi C, Pecorelli A, Lombardi S, Orsini E, Strazzabosco M, Sironi S. Eur J Radiol. 2018 Sep; 2018 Jul 20. PMID: 30150052.
Liver Tissue Classification Using an Auto-context-based Deep Neural Network with a Multi-phase Training Framework.Zhang F, Yang J, Nezami N, Laage-Gaupp F, Chapiro J, De Lin M, Duncan J. Patch Based Tech Med Imaging (2018). 2018 Sep; 2018 Sep 15. PMID: 32432233.
Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities.Dionne-Odom J, Njei B, Tita ATN. Clin Ther. 2018 Aug; 2018 Jul 5. PMID: 29983265.
Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept.Abajian A, Murali N, Savic LJ, Laage-Gaupp FM, Nezami N, Duncan JS, Schlachter T, Lin M, Geschwind JF, Chapiro J. J Vasc Interv Radiol. 2018 Jun; 2018 Mar 14. PMID: 29548875.
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.Pitroda SP, Khodarev NN, Huang L, Uppal A, Wightman SC, Ganai S, Joseph N, Pitt J, Brown M, Forde M, Mangold K, Xue L, Weber C, Segal JP, Kadri S, Stack ME, Khan S, Paty P, Kaul K, Andrade J, White KP, Talamonti M, Posner MC, Hellman S, Weichselbaum RR. Nat Commun. 2018 May 4; 2018 May 4. PMID: 29728604.
Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.Simon TG, King LY, Chong DQ, Nguyen LH, Ma Y, VoPham T, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Khalili H, Chung RT, Zhang X, Chan AT. Hepatology. 2018 May; 2018 Mar 26. PMID: 29152763.
Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells.Bugide S, Green MR, Wajapeyee N. Proc Natl Acad Sci U S A. 2018 Apr 10; 2018 Mar 26. PMID: 29581297.
Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching.Kaplan DE, Mehta R, D'Addeo K, Gade TP, Taddei TH. J Vasc Interv Radiol. 2018 Apr; 2018 Feb 22. PMID: 29477619.
Sensitivity and Reproducibility of Automated Feeding Artery Detection Software during Transarterial Chemoembolization of Hepatocellular Carcinoma.Chiaradia M, Izamis ML, Radaelli A, Prevoo W, Maleux G, Schlachter T, Mayer J, Luciani A, Kobeiter H, Tacher V. J Vasc Interv Radiol. 2018 Mar; 2018 Feb 3. PMID: 29402612.
Science to Practice: Decrypting the Enigma of Ablation-induced Off-Target Effects-Is Network Pathway Analysis the Final Piece of the Puzzle?Murali N, Laage-Gaupp FM, Chapiro J, Geschwind JF. Radiology. 2018 Feb. PMID: 29356646.
Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.Kwak YE, Stein SM, Lim JK. Dig Dis Sci. 2018 Jan; 2017 Nov 24. PMID: 29177849.
Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort study.Kaplan DE, Mehta R, D'Addeo K, Valderrama A, Taddei TH. Medicine (Baltimore). 2018 Jan. PMID: 29369224.
Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.Fowler KJ, Tang A, Santillan C, Bhargavan-Chatfield M, Heiken J, Jha RC, Weinreb J, Hussain H, Mitchell DG, Bashir MR, Costa EAC, Cunha GM, Coombs L, Wolfson T, Gamst AC, Brancatelli G, Yeh B, Sirlin CB. Radiology. 2018 Jan; 2017 Nov 1. PMID: 29091751.

2017

De-novo hepatocellular carcinoma after pediatric living donor liver transplantation.Torres-Landa S, Muñoz-Abraham AS, Fortune BE, Gurung A, Pollak J, Emre SH, Rodriguez-Davalos MI, Schilsky ML. World J Hepatol. 2017 Dec 28. PMID: 29359020.
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon Y Cajal S, Fasani R, Aguirre AJ, Ng K, Élez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M. Science. 2017 Dec 15; 2017 Nov 23. PMID: 29170280.
Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.Do Minh D, Chapiro J, Gorodetski B, Huang Q, Liu C, Smolka S, Savic LJ, Wainstejn D, Lin M, Schlachter T, Gebauer B, Geschwind JF. Eur Radiol. 2017 Dec; 2017 Jul 4. PMID: 28677067.
Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study.Reiss KA, Yu S, Mamtani R, Mehta R, D'Addeo K, Wileyto EP, Taddei TH, Kaplan DE. J Clin Oncol. 2017 Nov 1; 2017 Sep 5. PMID: 28872925.
Science to Practice: Molecular-targeted Drug Delivery in Combination with Radiofrequency Ablation of Liver Cancer: A Magic Bullet?Adam LC, Murali N, Chapiro J, Geschwind JF. Radiology. 2017 Nov. PMID: 29045226.
Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.Nagarajan A, Dogra SK, Sun L, Gandotra N, Ho T, Cai G, Cline G, Kumar P, Cowles RA, Wajapeyee N. Mol Cell. 2017 Aug 17; 2017 Aug 10. PMID: 28803777.
Two Cases of Primary Hepatic Neuroendocrine Tumors and a Review of the Current Literature.DeLuzio MR, Barbieri AL, Israel G, Emre S. Ann Hepatol. 2017 Jul-Aug. PMID: 28611270.
Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.Vilarinho S, Erson-Omay EZ, Mitchell-Richards K, Cha C, Nelson-Williams C, Harmancı AS, Yasuno K, Günel M, Taddei TH. J Hepatol. 2017 Jul; 2017 Mar 18. PMID: 28323122.
Non-alcoholic fatty liver disease: An expanded review.Benedict M, Zhang X. World J Hepatol. 2017 Jun 8. PMID: 28652891.
Science to Practice: Killing Dormant Cells-Is Targeting Autophagy the Key to Complete Tumor Response in Transarterial Chemoembolization?Savic LJ, Chapiro J, Geschwind JF. Radiology. 2017 Jun. PMID: 28514219.
Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Sahu S, Schernthaner R, Ardon R, Chapiro J, Zhao Y, Sohn JH, Fleckenstein F, Lin M, Geschwind JF, Duran R. Radiology. 2017 Jun; 2016 Nov 10. PMID: 27831830.
Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy.Sohn JH, Duran R, Zhao Y, Fleckenstein F, Chapiro J, Sahu S, Schernthaner RE, Qian T, Lee H, Zhao L, Hamilton J, Frangakis C, Lin M, Salem R, Geschwind JF. Clin Gastroenterol Hepatol. 2017 May; 2016 Nov 12. PMID: 27847278.
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study.Ippolito D, Querques G, Okolicsanyi S, Franzesi CT, Strazzabosco M, Sironi S. Eur J Radiol. 2017 May; 2017 Feb 20. PMID: 28583645.
American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.Jacobson IM, Lim JK, Fried MW. Gastroenterology. 2017 May; 2017 Mar 23. PMID: 28344022.
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.Benson AB 3rd, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Zhu AX, Hoffmann KG, Darlow S. J Natl Compr Canc Netw. 2017 May. PMID: 28476736.
Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.Gorodetski B, Chapiro J, Schernthaner R, Duran R, Lin M, Lee H, Lenis D, Stuart EA, Nonyane BA, Pekurovsky V, Tamrazi A, Gebauer B, Schlachter T, Pawlik TM, Geschwind JF. Eur Radiol. 2017 Feb; 2016 Jun 8. PMID: 27277261.
Intra-arterial therapies for liver cancer: assessing tumor response.Stroehl YW, Letzen BS, van Breugel JM, Geschwind JF, Chapiro J. Expert Rev Anticancer Ther. 2017 Feb; 2016 Dec 27. PMID: 27983883.
Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.Duran R, Mirpour S, Pekurovsky V, Ganapathy-Kanniappan S, Brayton CF, Cornish TC, Gorodetski B, Reyes J, Chapiro J, Schernthaner RE, Frangakis C, Lin M, Sun JD, Hart CP, Geschwind JF. Clin Cancer Res. 2017 Jan 15; 2016 Jul 20. PMID: 27440271.
The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma.Smolka S, Chapiro J, Manzano W, Treilhard J, Reiner E, Deng Y, Zhao Y, Hamm B, Duncan JS, Gebauer B, Lin M, Geschwind JF. Clin Imaging. 2017 Nov - Dec; 2017 Jun 7. PMID: 28668723.

2016

Liver-allocation policies for patients affected by HCC in Europe.De Carlis L, Di Sandro S, Centonze L, Lauterio A, Buscemi V, De Carlis R, Ferla F, Sguinzi R, Okolicsanyi S, Belli L, Strazzabosco M. Curr Transplant Rep. 2016 Dec; 2016 Oct 7. PMID: 28473952.
The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.Mulligan DC. Hepatology. 2016 Dec; 2016 Oct 25. PMID: 27641833.
Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.Zhao Y, Duran R, Chapiro J, Sohn JH, Sahu S, Fleckenstein F, Smolka S, Pawlik TM, Schernthaner R, Zhao L, Lee H, He S, Lin M, Geschwind JF. J Gastrointest Surg. 2016 Dec; 2016 Oct 6. PMID: 27714643.
Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.Mu L, Chapiro J, Stringam J, Geschwind JF. Cancer J. 2016 Nov/Dec. PMID: 27870678.
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.Wong CR, Nguyen MH, Lim JK. World J Gastroenterol. 2016 Oct 7. PMID: 27729736.
Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT.Schernthaner RE, Haroun RR, Duran R, Lee H, Sahu S, Sohn JH, Chapiro J, Zhao Y, Gorodetski B, Fleckenstein F, Smolka S, Radaelli A, van der Bom IM, Lin M, Geschwind JF. Cardiovasc Intervent Radiol. 2016 Oct; 2016 Jul 5. PMID: 27380872.
HIV, Aging, and Viral Coinfections: Taking the Long View.Taddei TH, Lo Re V 3rd, Justice AC. Curr HIV/AIDS Rep. 2016 Oct. PMID: 27614654.
Protective altruistic phlebotomy: hereditary haemochromatosis presenting as hepatocellular carcinoma in a non-cirrhotic 83-year-old man.Ooka K, Onyiuke I, Zhang X, Taddei TH. BMJ Case Rep. 2016 Sep 2; 2016 Sep 2. PMID: 27591041.
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.Ahn J, Lim JK, Lee HM, Lok AS, Nguyen M, Pan CQ, Mannalithara A, Te H, Reddy KR, Trinh H, Chu D, Tran T, Lau D, Leduc TS, Min A, Trong Le L, Bae H, Van Tran S, Do S, Hann HW, Wong C, Han S, Pillai A, Park JS, Tong M, Scaglione S, Woog J, Kim WR. Am J Gastroenterol. 2016 Sep; 2016 Jun 21. PMID: 27325221.
3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.Fleckenstein FN, Schernthaner RE, Duran R, Sohn JH, Sahu S, Zhao Y, Hamm B, Gebauer B, Lin M, Geschwind JF, Chapiro J. Eur Radiol. 2016 Sep; 2016 Jan 13. PMID: 26762942.
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study.Belli LS, Berenguer M, Cortesi PA, Strazzabosco M, Rockenschaub SR, Martini S, Morelli C, Donato F, Volpes R, Pageaux GP, Coilly A, Fagiuoli S, Amaddeo G, Perricone G, Vinaixa C, Berlakovich G, Facchetti R, Polak W, Muiesan P, Duvoux C. J Hepatol. 2016 Sep; 2016 May 17. PMID: 27212241.
Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.Geschwind JF, Chapiro J. Clin Adv Hematol Oncol. 2016 Aug. PMID: 27487101.
Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?Pahade JK, Juice D, Staib L, Israel G, Cornfeld D, Mitchell K, Weinreb J. Abdom Radiol (NY). 2016 Jul. PMID: 26800701.
Multimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors.Tacher V, Duran R, Lin M, Sohn JH, Sharma KV, Wang Z, Chapiro J, Gacchina Johnson C, Bhagat N, Dreher MR, Schäfer D, Woods DL, Lewis AL, Tang Y, Grass M, Wood BJ, Geschwind JF. Radiology. 2016 Jun; 2015 Dec 16. PMID: 26678453.
Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis.Njei B, Gupta N, Ewelukwa O, Ditah I, Foma M, Lim JK. Liver Int. 2016 May; 2015 Oct 1. PMID: 26352650.
Learning from the Melbourne experience: How reliable are cancer registry data for hepatocellular carcinoma?Taddei TH. Hepatology. 2016 Apr; 2016 Mar 1. PMID: 26764271.
Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.Stein SM, James ES, Deng Y, Cong X, Kortmansky JS, Li J, Staugaard C, Indukala D, Boustani AM, Patel V, Cha CH, Salem RR, Chang B, Hochster HS, Lacy J. Br J Cancer. 2016 Mar 29. PMID: 27022826.
Automatic bone removal for 3D TACE planning with C-arm CBCT: Evaluation of technical feasibility.Wang Z, Hansis E, Chen R, Duran R, Chapiro J, Sheu YR, Kobeiter H, Grass M, Geschwind JF, Lin M. Minim Invasive Ther Allied Technol. 2016; 2016 Feb 29. PMID: 26923140.
Focal hepatic glycogenosis associated with metastatic insulinoma presenting as mass lesions.Vyas M, Zhang X, Morrow JS, Jain D, Salem RR, West AB. Pathol Res Pract. 2016 Jan; 2015 Nov 26. PMID: 26627264.
A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study.Duran R, Sharma K, Dreher MR, Ashrafi K, Mirpour S, Lin M, Schernthaner RE, Schlachter TR, Tacher V, Lewis AL, Willis S, den Hartog M, Radaelli A, Negussie AH, Wood BJ, Geschwind JF. Theranostics. 2016; 2016 Jan 1. PMID: 26722371.

2015

Science to Practice: The Changing Face of Local Tumor Therapies-Do We Have to Think Systemically When Treating Cancer Locally?Chapiro J, Geschwind JF. Radiology. 2015 Aug. PMID: 26203703.
American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT. Gastroenterology. 2015 Jan; 2014 Oct 31. PMID: 25447850.
Emerging trends in hepatocellular carcinoma incidence and mortality.Njei B, Rotman Y, Ditah I, Lim JK. Hepatology. 2015 Jan; 2014 Nov 24. PMID: 25142309.

2014

Hepatocellular carcinoma: a comprehensive overview of surgical therapy.Fonseca AL, Cha CH. J Surg Oncol. 2014 Nov; 2014 Jun 4. PMID: 24894746.
Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic review.Nguyen LH, Chao D, Lim JK, Ayoub W, Nguyen MH. Clin Gastroenterol Hepatol. 2014 Aug; 2013 Dec 17. PMID: 24361419.
Notch signaling and new therapeutic options in liver disease.Morell CM, Strazzabosco M. J Hepatol. 2014 Apr; 2013 Dec 3. PMID: 24308992.
Management of sorafenib-related adverse events: a clinician's perspective.Brose MS, Frenette CT, Keefe SM, Stein SM. Semin Oncol. 2014 Feb; 2014 Jan 9. PMID: 24576654.
New frontier in liver cancer treatment: oncolytic viral therapy.Vilarinho S, Taddei TH. Hepatology. 2014 Jan; 2013 Nov 15. PMID: 23836532.

2013

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: the egg of columbus or another illusion?Kim AK, Dziura J, Strazzabosco M. Hepatology. 2013 Aug. PMID: 23703812.
Hepatocellular carcinoma: perspective of an oncologist.Stein SM. J Clin Gastroenterol. 2013 Jul. PMID: 23751802.
Surgical therapy for hepatocellular carcinoma: formulating a rational approach.Cha C. J Clin Gastroenterol. 2013 Jul. PMID: 23751801.
A multidisciplinary approach: group dynamics.Taddei TH. J Clin Gastroenterol. 2013 Jul. PMID: 23632364.
Consider the perspectives: interventional radiology.Pollak JS. J Clin Gastroenterol. 2013 Jul. PMID: 23632350.
The role of imaging in hepatocellular carcinoma: the present and future.Davarpanah AH, Weinreb JC. J Clin Gastroenterol. 2013 Jul. PMID: 23632342.
Radiology estimates of viable tumor percentage in hepatocellular carcinoma ablation cavities correlate poorly with pathology assessment.Hanson JA, Ason R, Weinreb J, Van Dyke A, Mitchell KA. Arch Pathol Lab Med. 2013 Mar. PMID: 23451750.

2012

Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival.Guo X, Schmitz JC, Kenney BC, Uchio EM, Kulkarni S, Cha CH. Cancer Sci. 2012 Aug; 2012 Jul 11. PMID: 22625651.

2011

FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients.Park LS, Tate JP, Justice AC, Lo Re V 3rd, Lim JK, Bräu N, Brown ST, Butt AA, Gibert C, Goetz MB, Rimland D, Rodriguez-Barradas MC, Dubrow R. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 2011 Oct 25. PMID: 22028407.
Systemic therapy in hepatocellular carcinoma.Wrzesinski SH, Taddei TH, Strazzabosco M. Clin Liver Dis. 2011 May. PMID: 21689622.

2010

Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma.Eltawil KM, Kidd M, Giovinazzo F, Helmy AH, Salem RR. World J Surg Oncol. 2010 May 24; 2010 May 24. PMID: 20497548.
Hepatocellular carcinoma: current management.Cha CH, Saif MW, Yamane BH, Weber SM. Curr Probl Surg. 2010 Jan. PMID: 19963083.

2008

Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.Iyer A, Robert ME, Bifulco CB, Salem RR, Jain D. Hum Pathol. 2008 Sep; 2008 Jul 7. PMID: 18602664.
Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.Kang SP, Taddei T, McLennan B, Lacy J. World J Gastroenterol. 2008 Mar 14. PMID: 18330959.

2007

Intraductal papillary cholangiocarcinoma associated with von Meyenberg complexes: a case report.Neto AG, Dainiak C, Qin L, Salem RR, Jain D. Dig Dis Sci. 2007 Oct; 2007 Mar 30. PMID: 17394067.

2006

Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.Yoo PS, Lopez-Soler RI, Longo WE, Cha CH. Clin Colorectal Cancer. 2006 Sep. PMID: 17026789.

2005

Squamous cell carcinoma of the pancreas.Brown HA, Dotto J, Robert M, Salem RR. J Clin Gastroenterol. 2005 Nov-Dec. PMID: 16208119.
Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia.Salem RR, Tray K. Ann Surg. 2005 Feb. PMID: 15650646.
Molecular mechanisms in hepatocellular carcinoma development.Cha C, Dematteo RP. Best Pract Res Clin Gastroenterol. 2005 Feb. PMID: 15757803.

2004

A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management.Cobey FC, Salem RR. Am J Surg. 2004 Feb. PMID: 14769302.
Surgical therapy for hepatocellular carcinoma.Cha C, Dematteo RP, Blumgart LH. Adv Surg. 2004. PMID: 15515627.

2002

Recurrent hepatocellular carcinoma: to resect or not to resect.Salem RR. J Clin Gastroenterol. 2002 Nov-Dec. PMID: 12394219.
Multiple angiomyolipomata of the liver: a case report.Tang LH, Hui P, Garcia-Tsao G, Salem RR, Jain D. Mod Pathol. 2002 Feb. PMID: 11850546.